TrialJournal of the National Cancer Institute. Monographs2024

A prospective cohort study comparing efficacy of 1 dose of quadrivalent human papillomavirus vaccine to 2 and 3 doses at an average follow up of 12 years postvaccination.

Sylla G Malvi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.